Background
N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic messenger RNA and regulates multiple RNA-related biological processes. M6A modifications of HIV-1 RNA have been reported, but hotspots and functional effects of m6A variations in HIV-1 transcripts remain poorly characterized.
Methods
We applied GLORI-seq to map m6A modifications at single-nucleotide resolution in 9 commonly used HIV-1–infected cell line models (5 J-Lat clones, J1.1, ACH2, 8E5, and U1) and in 2 ex vivo infection models with or without PMA/ionomycin stimulation. To validate the m6A sites identified and study their functional relevance, cells were incubated with two small-molecule inhibitors of the m6A methyltransferase METTL3 (STM3006 or STM2457). Consequences of m6A inhibition were determined by RT-ddPCR and by RNA-seq in 5 HIV-1 infected cell lines and in memory CD4+ T cells (mCD4+) isolated from 3 people living with HIV (PLWH) on suppressive ART.
Results
Across all 11 models, we consistently identified 8 m6A sites restricted to the last ~1.5kb of the 3′ end of HIV-1 transcripts. Although methylation levels at individual sites varied (25–95%), their overall patterns and positions were highly conserved. Interestingly, although PMA/ionomycin stimulation increased HIV-1 expression by 5- to 200- fold, it did not alter the location or extent of HIV-1 m6A modifications. METTL3 inhibition increased HIV-1 expression in selected models (ACH2, 8E5, J-Lat 10.6) by 2- to 8-fold, and also induced marked changes in host transcriptome [213-763 deregulated protein coding genes, padj<0.01, |log2FC|>1]. However, in mCD4+ cells from PLWH on ART, pharmacological METTL3 inhibition neither enhanced HIV-1 RNA expression nor led to detectable changes in cell-intrinsic recognition of viral transcripts or induction of interferon-stimulated genes; this was true when viral transcription was assessed in bulk CD4 T cells or in sorted CD4 T cells expressing p24 in response to stimulation with tat mRNA.
Conclusions
GLORI-seq combined with pharmacologic inhibition of METTL3 demonstrated that HIV-1 m6A modifications are restricted to the 3′ end of viral RNAs and maintained at conserved positions, independent of viral expression levels or integration sites. Global removal of m6A did not result in generalized increase of HIV-1 expression, suggesting an indirect and cell type-dependent role of m6A in HIV-1 transcriptional regulation.